Cargando…

Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses

Most patients with pancreatic cancer present with extensive metastasis at diagnosis, with a 5-year survival rate of approximately 5%, despite chemotherapy and surgery. New treatment modalities are needed to improve survival. Mesothelin is a tumor-associated antigen (TAA) in patients with pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Qingda, Valentini, Davide, Rao, Martin, Liu, Zhenjiang, Xie, Shanshan, Morgell, Ann, Dodoo, Ernest, Löhr, Matthias, Rangelova, Elena, del Chiaro, Marco, Ernberg, Ingemar, Maeurer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976477/ https://www.ncbi.nlm.nih.gov/pubmed/29854291 http://dx.doi.org/10.18632/oncotarget.25121

Ejemplares similares

IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy
por: Liu, Zhenjiang, et al.
Publicado: (2015)

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
por: Zhenjiang, Liu, et al.
Publicado: (2017)

Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
por: Meng, Qingda, et al.
Publicado: (2018)

A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer
por: Rangelova, Elena B, et al.
Publicado: (2014)

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
por: Meng, Qingda, et al.
Publicado: (2018)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
por: Meng, Qingda, et al.
Publicado: (2014)

Rapid expansion of TILs from patients with glioma and recognition of autologous tumor
por: Zhenjiang, Liu, et al.
Publicado: (2014)

T-Cell Therapy: Options for Infectious Diseases
por: Parida, Shreemanta K., et al.
Publicado: (2015)

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
por: Liu, Zhenjiang, et al.
Publicado: (2018)

Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells
por: Dodoo, Ernest, et al.
Publicado: (2014)

KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
por: Meng, Qingda, et al.
Publicado: (2018)

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme
por: Zhenjiang, Liu, et al.
Publicado: (2018)

Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
por: Valentini, Davide, et al.
Publicado: (2018)

Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
por: Valentini, Davide, et al.
Publicado: (2018)

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
por: Rao, Martin, et al.
Publicado: (2015)

Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
por: Rao, Martin, et al.
Publicado: (2019)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors
por: Hatterer, Eric, et al.
Publicado: (2020)

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)

New High Affinity Monoclonal Antibodies Recognize Non-Overlapping Epitopes On Mesothelin For Monitoring And Treating Mesothelioma
por: Zhang, Yi-Fan, et al.
Publicado: (2015)

Targeting mesothelin in ovarian cancer
por: Ghafoor, Azam, et al.
Publicado: (2018)

The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis
por: Sinclair, Georges, et al.
Publicado: (2018)

Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases
por: Sinclair, Georges, et al.
Publicado: (2019)

Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants*
por: Fausther, Michel, et al.
Publicado: (2017)

Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
por: Ye, Lin, et al.
Publicado: (2019)

Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin
por: Liu, Xiufen, et al.
Publicado: (2022)

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin
por: Snell, Daniel, et al.
Publicado: (2023)

Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning
por: Li, Qin, et al.
Publicado: (2016)

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
por: Yu, Yi, et al.
Publicado: (2011)

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022)

Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
por: Zhang, Zhiwei, et al.
Publicado: (2019)

Are there still indications for total pancreatectomy?
por: Del Chiaro, Marco, et al.
Publicado: (2016)

Modulating Mesothelin Shedding to Improve Therapy
por: Zhang, Yujian, et al.
Publicado: (2012)

Mesothelin as a biomarker for targeted therapy
por: Lv, Jiang, et al.
Publicado: (2019)

Whole CMV Proteome Pattern Recognition Analysis after HSCT Identifies Unique Epitope Targets Associated with the CMV Status
por: Pérez-Bercoff, Lena, et al.
Publicado: (2014)

Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2018)

Correction: Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
por: Zhang, Zhiwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6ucnp7eqsmm6truf9b3940hbk